Phibro Animal Health

Phibro Animal Health is a comprehensive provider of animal health products, offering a broad portfolio that includes vaccines, medicated feed additives, and nutritional products. The company supports a variety of animal species such as beef cattle, swine, poultry, dairy cattle, and aquaculture. Phibro Animal Health operates a division called Phibro Biotechnics, which specializes in microbial contract manufacturing services. The company has developed innovative solutions like the patented TAbic® vaccine delivery platform, which uses effervescent tablets for vaccine antigen delivery, and the pHi-Tech® vaccination management system to enhance vaccination program efficacy.

Phibro Animal Health has expanded its capabilities through strategic acquisitions, including MVP Laboratories, Biotay S.A., and Osprey Biotechnics. The company offers a range of nutritional specialty products, such as OmniGen®, Animate®, AB20®, Hy•D®, and Cellerate Yeast Solutions®. Additionally, Phibro provides custom autogenous vaccines tailored to specific farm needs and operates a Dynamic Quality Assurance® (DQA®) program to ensure product quality and safety.

Founded in 1946 as Philipp Brothers Chemicals, Inc., Phibro Animal Health has a long history in the industry. In 2000, the company acquired the global medicated feed additive business from Pfizer Inc. and completed its initial public offering in 2014. Phibro also supports sustainable aquaculture practices and offers microbial-based products for seed treatments and fertilizer companion products through Phibro Plant Solutions. The company’s Phibro Ethanol division provides solutions to optimize biofuel plant operations.